31.48
-0.92 (-2.84%)
| Penutupan Terdahulu | 32.40 |
| Buka | 32.36 |
| Jumlah Dagangan | 216,737 |
| Purata Dagangan (3B) | 392,355 |
| Modal Pasaran | 591,088,192 |
| Harga / Buku (P/B) | 2.35 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 7 May 2026 |
| EPS Cair (TTM) | -3.14 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 0.87% |
| Nisbah Semasa (MRQ) | 22.92 |
| Aliran Tunai Operasi (OCF TTM) | -62.89 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -69.56 M |
| Pulangan Atas Aset (ROA TTM) | -22.89% |
| Pulangan Atas Ekuiti (ROE TTM) | -41.60% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menaik | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | Tectonic Therapeutic, Inc. | Menurun | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | 1.5 |
| Aktiviti Orang Dalam | 1.5 |
| Volatiliti Harga | -5.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 4.0 |
| Purata | 0.90 |
|
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| % Dimiliki oleh Orang Dalam | 38.29% |
| % Dimiliki oleh Institusi | 59.27% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Aberdeen Group Plc | 31 Dec 2025 | 1,141,824 |
| 5Am Venture Management, Llc | 31 Dec 2025 | 606,660 |
| Vestal Point Capital, Lp | 31 Dec 2025 | 328,000 |
| Bollard Group Llc | 31 Dec 2025 | 302,953 |
| Pale Fire Capital Se | 31 Dec 2025 | 261,026 |
| Julat 52 Minggu | ||
| Median | 60.00 (90.60%) | |
| Jumlah | 1 Beli | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Truist Securities | 08 Jan 2026 | 60.00 (90.60%) | Beli | 21.46 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| MCNAMARA PETER | - | 35.87 | -6,262 | -224,618 |
| RUDDY MARCELLA K. | - | 35.87 | -10,000 | -358,700 |
| Jumlah Keseluruhan Kuantiti Bersih | -16,262 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -583,318 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 35.87 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| MCNAMARA PETER | Pegawai | 06 Mar 2026 | Jual automatik (-) | 6,262 | 35.87 | 224,618 |
| MCNAMARA PETER | Pegawai | 06 Mar 2026 | Pelaksanaan pilihan | 2,715 | - | - |
| RUDDY MARCELLA K. | Pegawai | 06 Mar 2026 | Jual automatik (-) | 10,000 | 35.87 | 358,700 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |